• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.晚期黑色素瘤患者接受免疫检查点抑制剂治疗期间血清乳酸脱氢酶与皮肤免疫相关不良事件的关联
J Am Acad Dermatol. 2022 Nov;87(5):1147-1149. doi: 10.1016/j.jaad.2022.02.024. Epub 2022 Feb 19.
2
Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation.黑色素瘤患者中基线乳酸脱氢酶与免疫相关不良事件之间的关联因免疫检查点抑制剂起始时的肿瘤分期而异。
J Am Acad Dermatol. 2023 Dec;89(6):1264-1268. doi: 10.1016/j.jaad.2023.07.1029. Epub 2023 Aug 8.
3
Prevalence of dermatological toxicities in patients with melanoma undergoing immunotherapy: Systematic review and meta-analysis.接受免疫治疗的黑色素瘤患者的皮肤病学毒性发生率：系统评价和荟萃分析。
PLoS One. 2021 Aug 6;16(8):e0255716. doi: 10.1371/journal.pone.0255716. eCollection 2021.
4
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.肿瘤浸润淋巴细胞作为晚期黑色素瘤患者免疫检查点阻断后皮肤免疫相关不良事件的预测生物标志物。
J Am Acad Dermatol. 2023 Jul;89(1):140-142. doi: 10.1016/j.jaad.2023.01.040. Epub 2023 Feb 15.
5
Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study.免疫检查点抑制剂相关白癜风及其对转移性黑色素瘤患者生存的影响：一项意大利黑色素瘤协作组研究
ESMO Open. 2021 Apr;6(2):100064. doi: 10.1016/j.esmoop.2021.100064. Epub 2021 Mar 10.
6
Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: A retrospective cohort study.在接受免疫检查点抑制剂治疗的黑色素瘤患者中，女性发生皮肤不良事件的几率更高：一项回顾性队列研究。
J Am Acad Dermatol. 2022 Aug;87(2):403-406. doi: 10.1016/j.jaad.2021.06.885. Epub 2021 Jul 10.
7
Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern.免疫检查点阻断治疗引起的具有间质肉芽肿模式的皮肤毒性。
J Cutan Pathol. 2018 Jul;45(7):504-507. doi: 10.1111/cup.13150. Epub 2018 Apr 23.
8
Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy.非皮肤免疫相关不良事件可预测免疫检查点抑制剂治疗后出现皮肤毒性的患者的总生存期和无进展生存期。
J Am Acad Dermatol. 2023 Jun;88(6):1368-1370. doi: 10.1016/j.jaad.2022.12.049. Epub 2023 Feb 2.
9
Efficacy of immune checkpoint inhibitors in patients with anorectal melanoma in association with immune-related adverse events: a case series.免疫检查点抑制剂在伴有免疫相关不良反应的肛门直肠黑色素瘤患者中的疗效：一项病例系列研究。
Clin J Gastroenterol. 2023 Dec;16(6):842-847. doi: 10.1007/s12328-023-01849-z. Epub 2023 Aug 26.
10
A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors.晚期黑色素瘤治疗的新前沿：在免疫检查点抑制剂时代重新定义临床管理。
Hum Vaccin Immunother. 2017 Aug 3;13(8):1765-1767. doi: 10.1080/21645515.2017.1322241. Epub 2017 May 8.

引用本文的文献

1
Clinical Features of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor versus Non-Immune Checkpoint Inhibitor Drugs in China: A Cross-Sectional Study and Literature Review.中国免疫检查点抑制剂与非免疫检查点抑制剂药物所致史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的临床特征：一项横断面研究及文献综述
J Inflamm Res. 2024 Oct 22;17:7591-7605. doi: 10.2147/JIR.S491791. eCollection 2024.
2
Early Changes in LIPI Score Predict Immune-Related Adverse Events: A Propensity Score Matched Analysis in Advanced Non-Small Cell Lung Cancer Patients on Immune Checkpoint Blockade.LIPI评分的早期变化可预测免疫相关不良事件：对接受免疫检查点阻断治疗的晚期非小细胞肺癌患者进行的倾向评分匹配分析
Cancers (Basel). 2024 Jan 20;16(2):453. doi: 10.3390/cancers16020453.
3
The role of laboratory tests as a prognostic marker for immune-checkpoint therapy in non-small cell lung cancer.实验室检查作为非小细胞肺癌免疫检查点治疗预后标志物的作用。
Transl Lung Cancer Res. 2023 Sep 28;12(9):1838-1841. doi: 10.21037/tlcr-23-566. Epub 2023 Sep 14.
4
Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis.生物标志物在免疫检查点抑制剂相关心肌炎管理中的作用。
Curr Cardiol Rep. 2023 Sep;25(9):959-967. doi: 10.1007/s11886-023-01915-5. Epub 2023 Jul 12.
5
A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma.一种基于铜死亡相关长链非编码RNA的新型风险模型预测了皮肤黑色素瘤患者的预后并揭示了其免疫微环境格局。
Front Genet. 2022 Jul 22;13:959456. doi: 10.3389/fgene.2022.959456. eCollection 2022.

本文引用的文献

1
Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker.转移性黑色素瘤患者血清乳酸脱氢酶升高的分子和免疫学关联：对旧生物标志物的新认识。
Cancer Med. 2020 Nov;9(22):8650-8661. doi: 10.1002/cam4.3474. Epub 2020 Oct 5.
2
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies.肿瘤突变负担与免疫检查点抑制治疗期间免疫相关不良事件之间存在显著相关性。
Cancer Immunol Immunother. 2020 May;69(5):683-687. doi: 10.1007/s00262-020-02543-6. Epub 2020 Mar 9.
3
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors.免疫相关不良反应和免疫检查点抑制剂的抗肿瘤疗效。
J Immunother Cancer. 2019 Nov 15;7(1):306. doi: 10.1186/s40425-019-0805-8.
4
Correction: Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.更正：基线肿瘤大小是接受帕博利珠单抗治疗的黑色素瘤患者总生存的独立预后因素。
Clin Cancer Res. 2018 Dec 1;24(23):6098. doi: 10.1158/1078-0432.CCR-18-3340.
5
Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab.基线肿瘤大小是接受帕博利珠单抗治疗的黑色素瘤患者总生存的独立预后因素。
Clin Cancer Res. 2018 Oct 15;24(20):4960-4967. doi: 10.1158/1078-0432.CCR-17-2386. Epub 2018 Apr 23.
6
Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.免疫检查点抑制剂的皮肤不良反应：皮肤毒性与免疫治疗
Am J Clin Dermatol. 2018 Jun;19(3):345-361. doi: 10.1007/s40257-017-0336-3.

Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.

作者信息

Asdourian Maria S, Otto Tracey S, Jacoby Ted V, Shah Nishi, Thompson Leah L, Blum Steven M, Reynolds Kerry L, Semenov Yevgeniy R, Lawrence Donald P, Sullivan Ryan J, Boland Genevieve M, Villani Alexandra-Chloé, Chen Steven T

机构信息

Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.

Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.

出版信息

J Am Acad Dermatol. 2022 Nov;87(5):1147-1149. doi: 10.1016/j.jaad.2022.02.024. Epub 2022 Feb 19.

DOI:10.1016/j.jaad.2022.02.024
PMID:35192899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10796160/
Abstract
摘要